References analysis of the Wikipedia article "Sertralin" in the Serbo-Croatian version

doi.org

dx.doi.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

Obach RS, Cox LM, Tremaine LM (2005). „Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: an in vitro study” (free access). Drug Metabolism & Disposition 33 (2): 262. DOI:10.1124/dmd.104.002428. PMID 15547048.

Flament MF, Lane RM, Zhu R, Ying Z (1999). „Predictors of an acute antidepressant response to fluoxetine and sertraline”. Int Clin Psychopharmacol 14 (5): 259–75. DOI:10.1097/00004850-199914050-00001. PMID 10529069.

O'Kearney RT, Anstey KJ, von Sanden C (2006). „Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents”. Cochrane Database of Systematic Reviews (Online) (4): CD004856. DOI:10.1002/14651858.CD004856.pub2. PMID 17054218. Pristupljeno 2011-04-29.

BSPS15 kriterijum je identifikovao 28 (21%) od pacijanata tretiranih sertralinom i 4 (6%) na plasibu da odgovaraju na lek. Redukcija od 50% u BSPS kriterijumu je identifikovala 47 (35%) pacijenata na sertralinu i 9 (13%) na plasibu. Konačno, 50% redukcija u MFQ-SP kriterijumu je identifikovala 53 (39%) pacijenata na sertralinu i 9 (13%) na plasibu. Van Ameringen M, Oakman J, Mancini C, Pipe B, Chung H (February 2004). „Predictors of response in generalized social phobia: effect of age of onset”. J Clin Psychopharmacol 24 (1): 42–8. DOI:10.1097/01.jcp.0000104909.75206.6f. PMID 14709946.

CGI-Improvement, mean ± SD: Sertraline = 2.3 ± 0.1 Placebo = 2.8 ± 0.1. CGI-Severity, mean ± SD: Change Sertraline = −1.3 ± 0.1; placebo = −1.0 ± 0.1 Davidson JR, Rothbaum BO, van der Kolk BA, Sikes CR, Farfel GM (2001). „Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder”. Arch. Gen. Psychiatry 58 (5): 485–92. DOI:10.1001/archpsyc.58.5.485. PMID 11343529.

Meyer JH, Wilson AA, Sagrati S, Hussey D, Carella A, Potter WZ, Ginovart N, Spencer EP, Cheok A, Houle S (2004). „Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [¹¹CDASB positron emission tomography study”]. The American Journal of Psychiatry 161 (5): 826–35. DOI:10.1176/appi.ajp.161.5.826. PMID 15121647.

Bolden-Watson C, Richelson E (1993). „Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes”. Life Sci. 52 (12): 1023–9. DOI:10.1016/0024-3205(93)90194-8. PMID 8445992.

Narita N, Hashimoto K, Tomitaka S, Minabe Y (1996). „Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain”. Eur. J. Pharmacol. 307 (1): 117–9. DOI:10.1016/0014-2999(96)00254-3. PMID 8831113.

Obach RS, Walsky RL, Venkatakrishnan K, Gaman EA, Houston JB, Tremaine LM (2006). „The utility of in vitro cytochrome P450 inhibition data in the prediction of drug-drug interactions”. J. Pharmacol. Exp. Ther. 316 (1): 336–48. DOI:10.1124/jpet.105.093229. PMID 16192315.

Ozdemir V, Naranjo CA, Herrmann N, Shulman RW, Sellers EM, Reed K, Kalow W (1998). „The extent and determinants of changes in CYP2D6 and CYP1A2 activities with therapeutic doses of sertraline”. Journal of Clinical Psychopharmacology 18 (1): 55–61. DOI:10.1097/00004714-199802000-00009. PMID 9472843.

Alfaro CL, Lam YW, Simpson J, Ereshefsky L (1999). „CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline”. Journal of Clinical Psychopharmacology 19 (2): 155–63. DOI:10.1097/00004714-199904000-00011. PMID 10211917.

Alfaro CL, Lam YW, Simpson J, Ereshefsky L (2000). „CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations”. Journal of Clinical Pharmacology 40 (1): 58–66. DOI:10.1177/00912700022008702. PMID 10631623.

DeVane CL, Liston HL, Markowitz JS (2002). „Clinical pharmacokinetics of sertraline”. Clinical Pharmacokinetics 41 (15): 1247–66. DOI:10.2165/00003088-200241150-00002. PMID 12452737.

Preskorn SH, Greenblatt DJ, Flockhart D, Luo Y, Perloff ES, Harmatz JS, Baker B, Klick-Davis A, Desta Z, Burt T (2007). „Comparison of duloxetine, escitalopram, and sertraline effects on cytochrome P450 2D6 function in healthy volunteers”. Journal of Clinical Psychopharmacology 27 (1): 28–34. DOI:10.1097/00004714-200702000-00005. PMID 17224709.

drugtopics.com

Verispan (18. 2. 2008.). „Top 200 Generic Drugs by Units in 2007” (PDF). Drug Topics. Arhivirano iz originala na datum 2012-07-11. Pristupljeno 30. 3. 2008. and Verispan (18. 2. 2008.). „Top 200 Brand Drugs by Units in 2007” (PDF). Drug Topics. Arhivirano iz originala na datum 2012-07-11. Pristupljeno 30. 3. 2008.

nih.gov

ncbi.nlm.nih.gov

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

Owens MJ, Morgan WN, Plott SJ, Nemeroff CB (1997). „Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites”. J. Pharmacol. Exp. Ther. 283 (3): 1305–22. PMID 9400006.

DeVane CL, Liston HL, Markowitz JS (2002). „Clinical pharmacokinetics of sertraline”. Clinical Pharmacokinetics 41 (15): 1247–66. DOI:10.2165/00003088-200241150-00002. PMID 12452737.

Hamilton SP, Nunes EV, Janal M, Weber L (2000). „The effect of sertraline on methadone plasma levels in methadone-maintenance patients”. The American Journal on Addictions / American Academy of Psychiatrists in Alcoholism and Addictions 9 (1): 63–9. PMID 10914294.

Sills TL, Greenshaw AJ, Baker GB, Fletcher PJ (April 1999). „The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin”. Psychopharmacology 143 (4): 426–32. PMID 10367561. Pristupljeno 2011-04-30.

webcitation.org

wikipedia.org

sh.wikipedia.org

Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

Sertralin (Serbo-Croatian Wikipedia)

archive.org

aspetjournals.org

dmd.aspetjournals.org

bentham.org

books.google.com

doi.org

dx.doi.org

drugtopics.com

jcheminf.com

nih.gov

ncbi.nlm.nih.gov

sciencedirect.com

springer.de

link.springer.de

webcitation.org

wikipedia.org

sh.wikipedia.org

wiley.com

onlinelibrary.wiley.com